bifido

PLATFORM TECHNOLOGY

biMUN

Immunomodulatory technology based on
human microbiome analysis.

Immune modulating technology through controlling microbiome.

  • Screening of pharmabiotics sp. modulating intestinal dendritic cells
  • Development of Bifidobacterium sp. activating T-regulatory cells
  • Development of Bifidobacterium sp. activating T-effector cells
  • Development of prebiotics promoting beneficial microbiome
IMMUNE MODULATOR IMMUNE MODULATOR

Core Competitive
Technology

  • Strategic screening
    of pharmabiotics

  • Modulation of
    microbiome

  • Safety evaluation

  • Mass production of
    strict anaerobes

Target indications
for pharmabiotics

  • Cancer immunotherapy
  • Rheumatoid arthritis
  • Sjogren's syndrome
top으로 이동